Sbir phase I topic 431, integrated cell culture chamber and flow guide for POC, walk-away operation for autologous T cell manufacturing
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91022C00021
- Awardee
-
Spatial Surgical LLC UEI NN3VQPSVNTJ6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $398,625
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20221 · Posted Jul 12, 2021
- Contract value 100% obligated
- $398,625.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 12 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Worcester, MA 01605, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $398,625 |
About this award
This is a Firm Fixed Price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Spatial Surgical LLC, a for-profit limited liability company, for $398,625. The contract is for the research and development of an "Integrated Cell Culture Chamber and Flow Guide for POC, Walk-Away Operation for Autologous T Cell Manufacturing". This aligns with the NCI's mission to support innovative medical technologies and cell-based therapies. The contract has a total small business set-aside, and the work is expected to be completed by September 2023. Spatial Surgical has also received other federal contracts and grants from agencies like the National Science Foundation to advance its computer-guided laser technology for orthopedic surgery and cell manufacturing.
Quick answers
Who was awarded contract 75N91022C00021?
75N91022C00021 was awarded to Spatial Surgical LLC by National Cancer Institute (National Institutes of Health) on August 25, 2022.
How much is contract 75N91022C00021 worth?
The government has obligated $398,625 on 75N91022C00021.
Was contract 75N91022C00021 competed?
The extent of competition for 75N91022C00021 was full and open competition after exclusion of sources. The government received 12 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award